Statement Of Cash Flows [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for interest income |
1 703
USD
|
1 218
USD
|
| Cash flows from (used in) operations before changes in working capital |
59 271
USD
|
39 969
USD
|
| Adjustments for decrease (increase) in biological assets |
7 659
USD
|
37 008
USD
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, trade and other receivables |
59,000
USD
|
91,000
USD
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, inventories |
2,000
USD
|
2 512
USD
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, property, plant and equipment |
-
USD
|
206,000
USD
|
| Adjustments for gain (loss) on disposals, property, plant and equipment |
427,000
USD
|
204,000
USD
|
| Income taxes paid, classified as operating activities |
622,000
USD
|
263,000
USD
|
| Cash flows from (used in) financing activities [abstract] | ||
| Proceeds from non-current borrowings |
1 681
USD
|
15 710
USD
|
| Repayments of non-current borrowings |
4 609
USD
|
4 925
USD
|
| Proceeds from current borrowings |
13 408
USD
|
13 915
USD
|
| Repayments of current borrowings |
32 804
USD
|
17 385
USD
|